Life ScienceCompany
Where is Alizyme - Renzapride headquartered?
Alizyme - Renzapride is headquartered in Cambridge, United Kingdom.
What sector is Alizyme - Renzapride in?
Alizyme - Renzapride is a life science company.
Alizyme - Renzapride is headquartered in Cambridge, United Kingdom.
Alizyme - Renzapride is a life science company.
Cambridge,
CB21 6GX
United Kingdom,
Alizyme plc - Renzapride is a 5-HT4 agonist and 5HT-3 antagonist, has been studied in more than 5,000 patients including one Phase 3 trial for the treatment of constipation-dominant irritable bowel syndrome (IBS-C). Renzapride demonstrated a small but statistically significant benefit in the Phase 3 study in IBS-C, however, Alizyme decided to not continue to pursue development of the drug for this indication.
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
